4-{[7-Chloro-4-oxo-3-(2-oxo-2-piperidin-1-yl-ethyl)-2-piperidin-1-ylmethyl-3,4-dihydro-quinazolin-6-ylmethyl]-prop-2-ynyl-amino}-N-pyridin-3-ylmethyl-benzamide

ID: ALA332428

PubChem CID: 10941449

Max Phase: Preclinical

Molecular Formula: C38H42ClN7O3

Molecular Weight: 680.25

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C#CCN(Cc1cc2c(=O)n(CC(=O)N3CCCCC3)c(CN3CCCCC3)nc2cc1Cl)c1ccc(C(=O)NCc2cccnc2)cc1

Standard InChI:  InChI=1S/C38H42ClN7O3/c1-2-16-45(31-13-11-29(12-14-31)37(48)41-24-28-10-9-15-40-23-28)25-30-21-32-34(22-33(30)39)42-35(26-43-17-5-3-6-18-43)46(38(32)49)27-36(47)44-19-7-4-8-20-44/h1,9-15,21-23H,3-8,16-20,24-27H2,(H,41,48)

Standard InChI Key:  MGBRABZRCJZSAL-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 49 54  0  0  0  0  0  0  0  0999 V2000
    0.9167   -1.1792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6250   -0.7625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9167   -2.0042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3375   -1.1792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6250   -2.4125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3375   -2.0042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2000   -0.7667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5125   -1.1792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7542   -1.1750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0417   -0.7667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0500   -2.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2333   -0.7667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4792   -1.1667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7625   -2.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4667   -0.7542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2000   -2.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1875   -1.1667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2000   -3.2417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8917    0.0750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6000    0.4875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1917   -0.7500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6250    0.0625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.6542   -1.1667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0125   -1.1667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5125   -2.0042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.6917   -1.9625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.3167    0.5083    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2375   -0.4542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2417   -1.8792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4167   -0.4542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4167   -1.8792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6167   -0.7292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9042   -1.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4750   -2.4125    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.1792   -0.3417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2333    0.0583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9458   -1.1875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6042    0.0875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9167   -3.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5083   -3.6542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0375    0.1083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3292   -1.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0417   -0.7167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6583   -0.7750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9458    0.4625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5125   -4.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9167   -4.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2042   -4.8875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6583    0.0500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  2  1  0
  5  3  2  0
  6  5  1  0
  7  1  1  0
  8  7  1  0
  9 10  2  0
 10  4  1  0
 11  6  1  0
 12  8  1  0
 13 23  1  0
 14 11  2  0
 15  9  1  0
 16  3  1  0
 17 15  1  0
 18 16  1  0
 19 35  1  0
 20 19  3  0
 21 13  1  0
 22  2  2  0
 23 29  2  0
 24 17  1  0
 25  8  2  0
 26 13  2  0
 27 38  1  0
 28 30  2  0
 29 31  1  0
 30 24  1  0
 31 24  2  0
 32 33  1  0
 33 21  1  0
 34 14  1  0
 35 17  1  0
 36 12  1  0
 37 12  1  0
 38 32  2  0
 39 18  1  0
 40 18  1  0
 41 43  1  0
 42 32  1  0
 43 42  2  0
 44 37  1  0
 45 36  1  0
 46 40  1  0
 47 39  1  0
 48 46  1  0
 49 44  1  0
  6  4  2  0
  9 14  1  0
 49 45  1  0
 47 48  1  0
 28 23  1  0
 41 27  2  0
M  END

Associated Targets(Human)

WIL2 (182 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 680.25Molecular Weight (Monoisotopic): 679.3038AlogP: 5.01#Rotatable Bonds: 11
Polar Surface Area: 103.67Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 6.21CX LogP: 3.95CX LogD: 3.93
Aromatic Rings: 4Heavy Atoms: 49QED Weighted: 0.22Np Likeness Score: -1.80

References

1. Bavetsias V, Skelton LA, Yafai F, Mitchell F, Wilson SC, Allan B, Jackman AL..  (2002)  The design and synthesis of water-soluble analogues of CB30865, a quinazolin-4-one-based antitumor agent.,  45  (17): [PMID:12166942] [10.1021/jm011081s]

Source